Trial intelligence / Profile preview

Intravaginal magnesium sulfate for labor pain and labor duration in nulliparous women

IRCT20200510047377N1Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in labor pain comparing Magnesium sulfate intravaginal with Placebo intravaginal (2 arms). Primary endpoints: Pain intensity at cervical dilatation 3-5 cm, Pain intensity at cervical dilatation 7-8 cm and 1 more. Started Jun 2020; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

labor pain

Beyond the preview

Go deeper on IRCT20200510047377N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200510047377N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call